Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$19.71 - $24.57 $61,061 - $76,117
3,098 Added 5.93%
55,297 $1.32 Million
Q4 2023

Feb 14, 2024

BUY
$11.39 - $21.67 $594,546 - $1.13 Million
52,199 New
52,199 $1.13 Million

Others Institutions Holding SNDX

About Syndax Pharmaceuticals Inc


  • Ticker SNDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,565,200
  • Market Cap $740M
  • Description
  • Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...
More about SNDX
Track This Portfolio

Track Lighthouse Investment Partners, LLC Portfolio

Follow Lighthouse Investment Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lighthouse Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lighthouse Investment Partners, LLC with notifications on news.